About Us

The consultancy business of La Merie Business Intelligence was established in 2002 by Ulrich Martin, MD, based on his extensive experience in the biopharmaceutical industry both as a physician specializing in pharmacology and as a co-founder and CEO of a product development biotech company.

La Merie Business Intelligence started the online presence of its biotech portal PipelineReview.com in 2006 as an R&D news provider and online shop for reports about research & development in the biopharmaceutical industry. PipelineReview.com is owned and operated by La Merie Publishing – Ulrich Martin.

As a courtesy to our audience, La Merie Publishing releases La Merie Biologics, a weekly FREE newsletter containing press releases about biologics from the previous week.

La Merie Publishing prepares brief and full reports. One of our top-selling listings are the annual editions of „Blockbuster Biologics – Sales of Recombinant Therapeutic Antibodies & Proteins“. La Merie Publishing products can be purchased in our online store at www.lamerie.com or at selected Resellers.

The focus of our products is directed towards therapeutic biologics, such as antibodies, proteins, peptides, vaccines and gene & cell therapy. We pay special attention to biosimilar antibodies and proteins, antibody drug conjugates, bispecific antibodies, TCR & CAR engineered antibodies, mRNA vaccines & therapeutics, oncolytic viruses and immuno-oncology in general.

To leverage our expertise and knowledge accumulated in our in-house database, we offer consultancy services for corporate customers, including, but not limited to, pipeline analysis reports, drug profiles and any other competitive intelligence elaboration of interest for our clients.

We respect your privacy and comply with the European Union General Data Protection Regulation (GDPR) (see our Privacy Policy at the bottom of this page for details and contact options).